MedTrace Logo

A Study to Evaluate the Safety and Effectiveness of JUVÉDERM Products in Adult Participants for the Change of Their Overall Facial Appearance

NCT07186595 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2026-02-23

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and effectiveness of JUVÉDERM products in adults seeking improvement in facial volume and/or skin quality.

Conditions

  • Mid Face Volume Deficit

Interventions

DEVICE

JUVÉDERM VOLUX XC

Injections

DEVICE

JUVÉDERM VOLUMA XC

Injections

DEVICE

JUVÉDERM VOLBELLA XC

Injections

DEVICE

JUVÉDERM VOLLURE XC

Injections

DEVICE

SKINVIVE by JUVÉDERM

Injections

DEVICE

JUVÉDERM ULTRA XC

Injections

DEVICE

JUVÉDERM ULTRA PLUS XC

Injections

Sponsors & Collaborators

Principal Investigators

  • ABBVIE INC. · AbbVie

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-25
Primary Completion
2026-08-31
Completion
2026-08-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07186595 on ClinicalTrials.gov